These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 26551178)

  • 21. Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: US Preventive Services Task Force Recommendation Statement.
    ; Davidson KW; Barry MJ; Mangione CM; Cabana M; Caughey AB; Davis EM; Donahue KE; Doubeni CA; Kubik M; Li L; Ogedegbe G; Pbert L; Silverstein M; Simon MA; Stevermer J; Tseng CW; Wong JB
    JAMA; 2021 Sep; 326(12):1186-1191. PubMed ID: 34581729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. When to give aspirin to prevent preeclampsia: application of Bayesian decision theory.
    Wright D; Wright A; Tan MY; Nicolaides KH
    Am J Obstet Gynecol; 2022 Feb; 226(2S):S1120-S1125. PubMed ID: 35177216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. US Preventive Services Task Force guideline supports low-dose aspirin for prevention of preeclampsia.
    Bond S
    J Midwifery Womens Health; 2015; 60(2):222-3. PubMed ID: 25782856
    [No Abstract]   [Full Text] [Related]  

  • 24. Hypertensive disorders of pregnancy pre- and postaspirin guideline publication in individuals with pregestational diabetes mellitus.
    Bruno AM; Allshouse AA; Metz TD; Theilen LH
    Am J Obstet Gynecol MFM; 2023 Apr; 5(4):100877. PubMed ID: 36708967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Summaries for patients: aspirin to prevent preeclampsia-related complications and death: U.S. Preventive Services Task Force recommendation statement.
    Ann Intern Med; 2014 Dec; 161(11):I28. PubMed ID: 25200275
    [No Abstract]   [Full Text] [Related]  

  • 26. First-trimester risk factors for preeclampsia development in women initiating aspirin by 16 weeks of gestation.
    Block-Abraham DM; Turan OM; Doyle LE; Kopelman JN; Atlas RO; Jenkins CB; Blitzer MG; Baschat AA
    Obstet Gynecol; 2014 Mar; 123(3):611-617. PubMed ID: 24513777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. USPSTF: Low-dose aspirin may help reduce risk of preeclampsia.
    Voelker R
    JAMA; 2014 May; 311(20):2055. PubMed ID: 24866995
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of low-dose aspirin on the prevention of preeclampsia and pregnancy outcomes: A randomized controlled trial from Shanghai, China.
    Gu W; Lin J; Hou YY; Lin N; Song MF; Zeng WJ; Shang J; Huang HF
    Eur J Obstet Gynecol Reprod Biol; 2020 May; 248():156-163. PubMed ID: 32217429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose of aspirin to prevent preterm preeclampsia in women with moderate or high-risk factors: A systematic review and meta-analysis.
    Van Doorn R; Mukhtarova N; Flyke IP; Lasarev M; Kim K; Hennekens CH; Hoppe KK
    PLoS One; 2021; 16(3):e0247782. PubMed ID: 33690642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gottesfeld-Hohler Memorial Foundation Risk Assessment for Early-Onset Preeclampsia in the United States: Think Tank Summary.
    Copel JA; Platt LD; Hobbins JC; Afshar Y; Grechukhina O; Mallampati D; Bromley B; Caughey AB; Grobman W; Han CS; Nicolaides K; Pettker C; Saade G; Sibai B; Simhan H; Sonek J; Werner E; Chescheir N
    Obstet Gynecol; 2020 Jan; 135(1):36-45. PubMed ID: 31809427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Budget Impact of Appropriate Low-Dose Aspirin Use for Primary and Secondary Cardiovascular Event Prevention in the Managed Care Setting.
    Carlton R; Coppolecchia R; Khalaf-Gillard K; Lennert B; Moradi A; Williamson T; Cameron J
    J Manag Care Spec Pharm; 2018 Nov; 24(11):1102-1111. PubMed ID: 30362916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The long-term cost-effectiveness of clopidogrel plus aspirin in patients undergoing percutaneous coronary intervention in Sweden.
    Lindgren P; Stenestrand U; Malmberg K; Jönsson B
    Clin Ther; 2005 Jan; 27(1):100-10. PubMed ID: 15763611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Society for Maternal-Fetal Medicine Special Statement: Prophylactic low-dose aspirin for preeclampsia prevention-quality metric and opportunities for quality improvement.
    ; Combs CA; Kumar NR; Morgan JL;
    Am J Obstet Gynecol; 2023 Aug; 229(2):B2-B9. PubMed ID: 37146704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of adherence to aspirin for preeclampsia prophylaxis and reasons for nonadherence.
    Olson DN; Russell T; Ranzini AC
    Am J Obstet Gynecol MFM; 2022 Sep; 4(5):100663. PubMed ID: 35580761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Economic evaluation of clopidogrel in acute coronary syndrome patients without ST-segment elevation in Greece: a cost-utility analysis.
    Kourlaba G; Fragoulakis V; Maniadakis N
    Appl Health Econ Health Policy; 2012 Jul; 10(4):261-71. PubMed ID: 22667992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis.
    Bujold E; Roberge S; Lacasse Y; Bureau M; Audibert F; Marcoux S; Forest JC; Giguère Y
    Obstet Gynecol; 2010 Aug; 116(2 Pt 1):402-414. PubMed ID: 20664402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Usefulness of aspirin therapy in high-risk pregnant women with abnormal uterine artery Doppler ultrasound at 14-16 weeks pregnancy: randomized controlled clinical trial.
    Ebrashy A; Ibrahim M; Marzook A; Yousef D
    Croat Med J; 2005 Oct; 46(5):826-31. PubMed ID: 16158479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of aspirin response signature gene expression on preterm birth and preeclampsia among women with lupus: a pilot study.
    Eudy AM; Voora D; Myers RA; Clowse MEB
    Lupus; 2019 Dec; 28(14):1640-1647. PubMed ID: 31684818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of NICE and USPSTF guidelines for identifying women at high risk of pre-eclampsia for tailoring aspirin prophylaxis in pregnancy: An individual participant data meta-analysis.
    Al-Rubaie ZTA; Askie LM; Hudson HM; Ray JG; Jenkins G; Lord SJ
    Eur J Obstet Gynecol Reprod Biol; 2018 Oct; 229():159-166. PubMed ID: 30199814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screen or not to screen for peripheral arterial disease: guidance from a decision model.
    Vaidya A; Joore MA; Ten Cate-Hoek AJ; Ten Cate H; Severens JL
    BMC Public Health; 2014 Jan; 14():89. PubMed ID: 24476213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.